| Diane S Krause, MD | |
|
135 College St, New Haven, CT 06510-2483 | |
| (203) 688-6959 | |
| (203) 737-4051 |
| Full Name | Diane S Krause |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 135 College St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780675199 | NPI | - | NPPES |
| 001348946 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 034894 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane S Krause, MD Po Box 9805, 300 George St 6th Floor, New Haven, CT 06536-0805 Ph: () - | Diane S Krause, MD 135 College St, New Haven, CT 06510-2483 Ph: (203) 688-6959 |
News Archive
A groundbreaking new study shows that eaters of lower energy dense breakfast have improved diet quality, and may have a better ability to maintain a healthy weight.
Thousands of men, women and children experience family violence each year, according to the U.S. Department of Justice. Traditionally, therapy for violence survivors has predominantly focused on evaluating their trauma and pain. In contrast, a University of Missouri researcher broadens the therapeutic focus to empower survivors through highlighting their resilience, resourcefulness, and ability to overcome adversity.
An international team of researchers has developed a non-invasive blood test that can detect whether an individual has one of five common types of cancers, four years before the condition can be diagnosed with current methods. The test detects stomach, esophageal, colorectal, lung and liver cancer.
Shire plc the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(escitlopram) for Major Depressive Disorder (MDD).
Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca's clinical pharmacology studies across multiple therapy areas and around the globe.
› Verified 8 days ago
Dr. Barton Charles Kenney, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Edward S Lee, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Melissa Anne Much, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York St # T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Haris Mirza, MD Pathology Medicare: Medicare Enrolled Practice Location: Yale School Of Medicine, Dept. Of Pathology, 20 York St, New Haven, CT 06510 Phone: 877-925-3522 Fax: 203-737-5388 | |
Raffaella Morotti, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 310 Cedar St, Pathology Department, New Haven, CT 06510 Phone: 203-737-6325 | |
Dr. Richard Rodion Rathbone, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, Yale-new Haven Hospital, New Haven, CT 06504 Phone: 203-688-2439 Fax: 203-688-5103 | |
Dr. Mahboubeh Rahmani, MD Pathology Medicare: Medicare Enrolled Practice Location: 310 Cedar St, New Haven, CT 06510 Phone: 203-737-2115 |